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approximately 8 hours. Flux rates of crystalline INH across
intestinal mucosa tended to be higher than those for tabletted
INH during the entire experiment, but were only significantly
different (p < 0.05) after 10 hours.
Discussion
We recently demonstrated that a continuous flow-through
mucosal perfusion system with intestinal mucosa showed
promise as an in vitro method for determining the permeability
of agents from the gastrointestinal tract for drug registration
purposes.4 However, simultaneously, we observed that
intestinal mucosa used in the above system was not very
permeable to molecules with weights (Mw) > 500 Da. We
therefore suggested that other mucosae, e.g. vaginal mucosa,
might have to be considered as substitutes if large Mw agents
are to be compared for BA/BE. Akin to other hydrophilic
compounds, INH (Mw = 137.14 Da) probably permeates the
intestinal mucosa via intercellular routes, the mucosal
membrane in conjunction with the epithelial tight junctions
providing the rate-limiting barrier.6
Although there was a tendency for flux rates of crystalline
INH to be higher than those of the tabletted form, these
differences were only significantly different after 10 hours (Fig.
1). A possible explanation is that the presence of the soluble
exipients in the tablets may alter the permeability properties of
INH across this barrier. However, it is clear that the intestinal
mucosal barrier appears to discriminate between the diffusion
rates of what is the same molecule with and without exipients.
In conclusion, we have shown that intestinal mucosa has
barrier properties which may be useful to assess BA/BE
properties of therapeutically active compounds in vitro. Further
studies using the above system are therefore indicated. 
Pieter van der Bijl
Heiner I Seifart
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To the Editor: Asymptomatic patients may be referred for a
haematology opinion when the routine blood count reveals
elevation in haemoglobin level, haematocrit or red cell count.1
There is an all too cavalier approach to this abnormality, which
is not only an independent risk factor for arterial or venous
thromboembolic disease2 but may signal unsuspected
underlying cardiac  or pulmonary pathology.3 Infrequently
these findings may draw attention to an otherwise silent
myeloproliferative syndrome in the form of primary
proliferative polycythaemia or polycythaemia rubra vera of
old.4 Occasionally, and of major clinical importance, is
inappropriate erythropoietin production by tumours, including
kidney tumours.5
A systematic approach to this problem  is essential.1 The first
step is to distinguish spurious from absolute erythrocytosis by
simultaneous determination of red cell mass and plasma
volume6 since the latter may be independently reduced in a
number of situations, including cigarette smoking.7 In the
majority of cases the most common cause is found in the lungs
with desaturation that enhances normal erythropoietin
production via a renal sensing mechanism. Less frequently
encountered is right-to-left shunting at the level of the heart or
the great vessels. Conversely, increases in neutrophil and
platelet count signal autonomous haematopoiesis in chronic
myeloproliferative syndromes. Less frequent, but of major
importance, is the need to recognise individuals with ectopic
production of erythropoietin; of these the classic example
remains cerebellar haemangioblastoma.1 More common causes
are found in renal cell carcinoma,5 uterine fibroids,8 and
haemangiomas of the liver9 and lung.10
A case is reported here to illustrate the occurrence of
symptomatic expansion of red cell mass as a reminder to
search carefully for otherwise silent tumours in this clinical
context.
A 54-year-old woman was referred by her primary care
physician with a haemoglobin of 183 g/l, a packed cell volume
of 55%, and normal platelet and white cell count. Her history
dated back 6 weeks. While at a health farm she had had routine
blood tests done primarily to define her endocrine status as a
basis for postmenopausal hormone replacement therapy.
Seventy-five per cent thyroidectomy had been carried out 3
years previously for a benign lesion. She was on 100 µg of
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thyroid hormone replacement daily. The remainder of the
physical examination was negative. The erythrocytosis was
attributed to smoking but formal pulmonary testing showed no
abnormality and functional studies were all within the normal
range. In view of the family history of ischaemic heart disease,
cardiological assessment was requested but no cause was
found for her blood count abnormality, with the only
additional feature being total cholesterol of 8.4 mmol/l. Whole
blood viscosity was elevated and a series of venesections was
undertaken while searching for possible sources of ectopic
hormone production. Clinical reassessment failed to reveal any
palpable liver, spleen, kidney, uterus or other masses. The
computed tomography (CT) scan exposed a non-homogeneous
and partially calcified exophytic mass in the lower part of the
right kidney less than 3 cm in greatest diameter (Fig. 1). There
was no evidence of perinephric or vascular invasion and the
imaging features were compatible with renal cell carcinoma,
which often exhibits variable parenchymal density with
calcification in up to 31% of cases.11 Resection and the
postoperative course were uneventful. Histopathological
examination revealed a stage T1 grade 1 renal cell carcinoma.
Haematology returned to normal within 4 weeks.
There is a general underappreciation of the hazards linked to
erythrocytosis.1 When part of a myeloproliferative syndrome in
the form of primary proliferative polycythaemia, the risk of
premature vascular disease is increased by concurrent
thrombocytosis, and there may also be a decrease in naturally
occurring anticoagulants and acquired elevation in
homocysteine levels.In most circumstances the causative lesion
lies in the pulmonary or vascular systems. However, in the
absence of demonstrable pathology it is important to search for
benign or malignant lesions that may be producing
erythropoietin. In the latter situation the risk is increased
because there may be associated elevations in fibrinogen and
factor VIII integral to the inflammatory process, reactive
thrombocytosis,12 activation of the clotting system through the
tissue factor — VII — over-expression and acquired or
secondary hyperhomocysteinaemia. These various
inflammatory pathophysiological mechanisms may all occur
together in neoplasia  and are the basis for resection that
simultaneously reduces erythropoietin drive on the marrow
and corrects acquired risk factors for thromboembolic disease.
This point was recently illustrated in a case where a rare
cerebellar hemangioblastoma was located and resection re-
established physiological levels of haemoglobin. 1
In conclusion, an example of erythrocytosis due to ectopic
hormonal production by clinically silent renal tumour is
described. Return of red cell mass to normal following
resection is presumptive evidence of cause and effect. Although
unusual, this association is clinically relevant and meticulous
search for such causes is appropriate in patients with otherwise
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Fig. 1. Renal cell carcinoma. CT scan with contrast at the level of the
lower pole of the right kidney. Exophytic partially calcified tumour
(arrowheads) projects laterally and lies posterior to the ascending
colon (open arrow).
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